Amyris Biotech
Creates renewable products, focusing on fuels and chemicals.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD822m—1.2b (Dealroom.co estimates Jun 2010.)
Emeryville California (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$20.0m | Series A | ||
N/A | Series A | ||
N/A | Series B | ||
N/A | N/A | Seed | |
N/A | N/A | Series B | |
$66.1m | Series B | ||
N/A | Series C | ||
N/A | N/A | Grant | |
$133m | Series D | ||
N/A | N/A | IPO | |
N/A | N/A | Post IPO Equity | |
N/A | N/A | Post IPO Equity | |
N/A | N/A | Post IPO Equity | |
N/A | $30.0m | Post IPO Debt | |
N/A | $10.9m | Post IPO Debt | |
$141m | Post IPO Equity | ||
N/A | N/A | Post IPO Equity | |
$50.0m | Post IPO Equity | ||
N/A | Grant | ||
N/A | $46.0m | Post IPO Equity | |
$34.0m | Post IPO Equity | ||
N/A | $200m | Private Placement VC | |
* | N/A | $300m | Post IPO Equity |
* | N/A | $400m | Post IPO Debt |
Total Funding | AUD648m |
Related Content
Recent News about Amyris Biotech
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Amyris Biotech
EditACQUISITION by Amyris Biotech Sep 2021
ACQUISITION by Amyris Biotech Aug 2021